Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

239 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Pituitary adenoma or neuroendocrine tumour: the need for an integrated prognostic classification.
Ho KKY, Kaiser UB, Chanson P, Gadelha M, Wass J, Nieman L, Little A, Aghi MK, Raetzman L, Post K, Raverot G, Borowsky AD, Erickson D, Castaño JP, Laws ER, Zatelli MC, Sisco J, Esserman L, Yuen KCJ, Reincke M, Melmed S. Ho KKY, et al. Among authors: castano jp. Nat Rev Endocrinol. 2023 Nov;19(11):671-678. doi: 10.1038/s41574-023-00883-8. Epub 2023 Aug 17. Nat Rev Endocrinol. 2023. PMID: 37592077 Review.
Expression of functional KISS1 and KISS1R system is altered in human pituitary adenomas: evidence for apoptotic action of kisspeptin-10.
Martínez-Fuentes AJ, Molina M, Vázquez-Martínez R, Gahete MD, Jiménez-Reina L, Moreno-Fernández J, Benito-López P, Quintero A, de la Riva A, Diéguez C, Soto A, Leal-Cerro A, Resmini E, Webb SM, Zatelli MC, degli Uberti EC, Malagón MM, Luque RM, Castaño JP. Martínez-Fuentes AJ, et al. Among authors: castano jp. Eur J Endocrinol. 2011 Mar;164(3):355-62. doi: 10.1530/EJE-10-0905. Epub 2010 Dec 17. Eur J Endocrinol. 2011. PMID: 21169415
International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature.
Günther T, Tulipano G, Dournaud P, Bousquet C, Csaba Z, Kreienkamp HJ, Lupp A, Korbonits M, Castaño JP, Wester HJ, Culler M, Melmed S, Schulz S. Günther T, et al. Among authors: castano jp. Pharmacol Rev. 2018 Oct;70(4):763-835. doi: 10.1124/pr.117.015388. Pharmacol Rev. 2018. PMID: 30232095 Free PMC article. Review.
Antagonists of Growth Hormone-Releasing Hormone Inhibit the Growth of Pituitary Adenoma Cells by Hampering Oncogenic Pathways and Promoting Apoptotic Signaling.
Gesmundo I, Granato G, Fuentes-Fayos AC, Alvarez CV, Dieguez C, Zatelli MC, Congiusta N, Banfi D, Prencipe N, Leone S, Brunetti L, Castaño JP, Luque RM, Cai R, Sha W, Ghigo E, Schally AV, Granata R. Gesmundo I, et al. Among authors: castano jp. Cancers (Basel). 2021 Aug 5;13(16):3950. doi: 10.3390/cancers13163950. Cancers (Basel). 2021. PMID: 34439107 Free PMC article.
Regulation of pituitary cell function by adiponectin.
Rodriguez-Pacheco F, Martinez-Fuentes AJ, Tovar S, Pinilla L, Tena-Sempere M, Dieguez C, Castaño JP, Malagon MM. Rodriguez-Pacheco F, et al. Among authors: castano jp. Endocrinology. 2007 Jan;148(1):401-10. doi: 10.1210/en.2006-1019. Epub 2006 Oct 12. Endocrinology. 2007. PMID: 17038552
Truncated somatostatin receptor variant sst5TMD4 confers aggressive features (proliferation, invasion and reduced octreotide response) to somatotropinomas.
Luque RM, Ibáñez-Costa A, Neto LV, Taboada GF, Hormaechea-Agulla D, Kasuki L, Venegas-Moreno E, Moreno-Carazo A, Gálvez MÁ, Soto-Moreno A, Kineman RD, Culler MD, Gahete MD, Gadelha MR, Castaño JP. Luque RM, et al. Among authors: castano jp. Cancer Lett. 2015 Apr 10;359(2):299-306. doi: 10.1016/j.canlet.2015.01.037. Epub 2015 Jan 28. Cancer Lett. 2015. PMID: 25637790 Free PMC article.
The expression of the truncated isoform of somatostatin receptor subtype 5 associates with aggressiveness in medullary thyroid carcinoma cells.
Molè D, Gentilin E, Ibañez-Costa A, Gagliano T, Gahete MD, Tagliati F, Rossi R, Pelizzo MR, Pansini G, Luque RM, Castaño JP, degli Uberti E, Zatelli MC. Molè D, et al. Among authors: castano jp. Endocrine. 2015 Nov;50(2):442-52. doi: 10.1007/s12020-015-0594-x. Epub 2015 Apr 9. Endocrine. 2015. PMID: 25854304
Splicing Machinery is Dysregulated in Pituitary Neuroendocrine Tumors and is Associated with Aggressiveness Features.
Vázquez-Borrego MC, Fuentes-Fayos AC, Venegas-Moreno E, Rivero-Cortés E, Dios E, Moreno-Moreno P, Madrazo-Atutxa A, Remón P, Solivera J, Wildemberg LE, Kasuki L, López-Fernández JM, Gadelha MR, Gálvez-Moreno MA, Soto-Moreno A, Gahete MD, Castaño JP, Luque RM. Vázquez-Borrego MC, et al. Among authors: castano jp. Cancers (Basel). 2019 Sep 26;11(10):1439. doi: 10.3390/cancers11101439. Cancers (Basel). 2019. PMID: 31561558 Free PMC article.
A Somatostatin Receptor Subtype-3 (SST3) Peptide Agonist Shows Antitumor Effects in Experimental Models of Nonfunctioning Pituitary Tumors.
Vázquez-Borrego MC, Gupta V, Ibáñez-Costa A, Gahete MD, Venegas-Moreno E, Toledano-Delgado Á, Cano DA, Blanco-Acevedo C, Ortega-Salas R, Japón MA, Barrera-Martín A, Vasiljevic A, Hill J, Zhang S, Halem H, Solivera J, Raverot G, Gálvez MA, Soto-Moreno A, Paez-Pereda M, Culler MD, Castaño JP, Luque RM. Vázquez-Borrego MC, et al. Among authors: castano jp. Clin Cancer Res. 2020 Feb 15;26(4):957-969. doi: 10.1158/1078-0432.CCR-19-2154. Epub 2019 Oct 17. Clin Cancer Res. 2020. PMID: 31624102
239 results